Announcements Trials
Browse Landscape

Phase

Phase 4 5Phase 3 2Phase 2 1

Status

Completed 3Terminated 2

Sponsor Class

INDUSTRY 5NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Classical hematology 5

Conditions

Anemia 5

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × epoetin beta × Clear all
NCT00776425 2017-07-02

A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies

Hoffmann-La Roche

Phase 4 Completed
117 enrolled
Classical hematology

Anemia

NCT02554942 2016-11-02

A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors

Hoffmann-La Roche

Phase 4 Completed
28 enrolled
Classical hematology

Anemia

NCT02564094 2016-11-02

A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies

Hoffmann-La Roche

Phase 4 Completed
54 enrolled
Classical hematology

Anemia

NCT02608060 2016-11-02

A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B

Hoffmann-La Roche

Phase 4 Terminated
4 enrolled
Classical hematology

Anemia

NCT02624141 2016-11-02

A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy

Hoffmann-La Roche

Phase 4 Terminated
10 enrolled
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡